[1] |
Chinese Society of Spleen and Portal Hypertension Surgery, Chinese Society of Surgery, Chinese Medical Association. Expert consensus on diagnosis and treatment of esophagogastric variceal bleeding in cirrhotic portal hypertension (2019 edition)[J]. Chin J Dig Surg, 2019, 18(12): 1087-1093. (in Chinese)
中华医学会外科学分会脾及门静脉高压外科学组. 肝硬化门静脉高压症食管、胃底静脉曲张破裂出血诊治专家共识(2019版)[J]. 中华消化外科杂志, 2019, 18 (12): 1087-1093.
|
[2] |
SANYAL AJ, BOSCH J, BLEI A, et al. Portal hypertension and its complications[J]. Gastroenterology, 2008, 134(6): 1715-1728. DOI: 10.1053/j.gastro.2008.03.007
|
[3] |
GONZALEZ-AGUIRRE AJ, LIN O, CHO C, et al. Transjugular liver biopsy in a multiple myeloma patient with hepatomegaly, portal hypertension and "Miliary" liver lesions: A case report[J]. J Gastrointest Dig Syst, 2016, 6(1): 390. http://europepmc.org/abstract/MED/28775913
|
[4] |
RAHHAL FE, SCHADE RR, NAYAK A, et al. Hepatic failure caused by plasma cell infiltration in multiple myeloma[J]. World J Gastroenterol, 2009, 15(16): 2038-2040. DOI: 10.3748/wjg.15.2038
|
[5] |
MUHAMMAD KHAN M, UR RASHID M, ULLAH W, et al. Rare case of acute on chronic hepatic failure in a patient with multiple myeloma-associated amyloidosis[J]. BMJ Case Rep, 2020, 13(1): e231563. DOI: 10.1136/bcr-2019-231563
|
[6] |
D'ALITTO F, SCHERZ A, MARGINI C, et al. Portal hypertension and a stiff liver[J]. Cureus, 2018, 10(6): e2768. http://www.ncbi.nlm.nih.gov/pubmed/30101047
|
[7] |
GIRNIUS S, SELDIN DC, SKINNER M, et al. Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease[J]. Haematologica, 2009, 94(7): 1029-1032. DOI: 10.3324/haematol.2008.001925
|
[8] |
KUMAR KS, LEFKOWITCH J, RUSSO MW, et al. Successful sequential liver and stem cell transplantation for hepatic failure due to primary AL amyloidosis[J]. Gastroenterology, 2002, 122(7): 2026-2031. http://europepmc.org/abstract/MED/12055607
|